Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Hi Rambo, I’m not great with links but if you go on her LinkedIn page and scroll down to contacts, it give you Novartis website details, yet she left there in Dec 2015. Maybe nothing in it but surely you would update that part.
It easy for them to put that in the Rns as it is true but avacta have also been saying that since Ava 6000 went into human trials.
They are not going to say CC has been given this role because we are in discussions with Big pharma about a TO/LD or partnership deal.
We won’t find that out until it’s all been finalised and signed off.
I’m here for the long haul and genuinely think avacta is going to be a power house of a company .
Surely we became a clinical stage company a few years ago?
Now it might not be a TO but I firmly believe someone behind the scenes is commanding these changes . Very possible a large partner (which I would prefer) but in my eyes there is something big happening.
Hi Penny
I thought the same when she was was given the new title, why was she not made the CMO or similar type roll.
Why did she become just the head of r&d, Is it because avacta is in the process of being taken over by a very large pharma that already has these people in place and are starting to pull strings.
I sold my business five years ago and for six months, whilst DD was going on I was under strict NDAs
Not one of my staff (other than my Pa) knew what was going on until the contract had been signed. I had to keep completely silent on the matter. Which wasn’t easy.
This brings me back to the “funding? Don’t worry about that “message and AS saying that’s as far as he can go with reassuring shareholders.
Some of my staff at the time had worries as they could sense something wasn’t right and all I could do was assure them everything would be fine because I knew where the company was going.
When I sold, I stayed with the company to help them through a transition period, I lost my director status and just became a manager.
Now I know all situations are different and my company wasn’t anything to do with pharma or on any kind of scale like this is but, I do look at it from a position that I have been in myself and do see similarities.
Looking at the likes on LinkedIn since CC put the same message on there as she did on Twitter you can see just how many top professionals at different pharma companies are aware of just what is going on here at avacta.